Source: Annual Congress 2008 - Clinical trial - Understanding the potential long-term impacts on function with Tiotropium: the UPLIFT trial
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Tashkin (Los Angeles, Ca, United States of America). Understanding the potential long-term impacts on function with Tiotropium: the UPLIFT trial - Safety data. Annual Congress 2008 - Clinical trial - Understanding the potential long-term impacts on function with Tiotropium: the UPLIFT trial

Member's Comments

Juan Carlos Figueroa Casas - 13.10.2008 02:42
Not possible to comment (it is not in the web despite announcement made during meeting).

Related content which might interest you: Understanding the potential long-term impacts on function with Tiotropium: the UPLIFT trial - Design and efficacy data Source: Annual Congress 2008 - Clinical trial - Understanding the potential long-term impacts on function with Tiotropium: the UPLIFT trial Year: 2008 A prospective observational study of the impact of COPD on daily life following the initiation of indacaterol Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Effectiveness of a spirometric quality assurance program in a large-scale global COPD trial (UPLIFT) Source: Eur Respir J 2004; 24: Suppl. 48, 32s Year: 2004 Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial Source: Eur Respir J 2010; 35: 287-294 Year: 2010 Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability Source: Eur Respir J, 51 (2) 1701531; 10.1183/13993003.01531-2017 Year: 2018 Safety of tiotropium in patients with cardiac events in the UPLIFT® trial Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Combined tiotropium + olodaterol influences physical functioning in COPD: Results of an open-label observational study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Effectiveness of combination therapy with tiotropium in COPD. A secondary analysis of the UPLIFT trial Source: Annual Congress 2009 - Functional insights into COPD Year: 2009 Safety of formoterol in asthma clinical trials: an update Source: Eur Respir J 2014; 43: 103-114 Year: 2004 Evaluating cardiac safety of tiotropium in patients with COPD: Combined analysis of Holter-ECG data from four trials Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Efficacy and safety profile of xanthines in COPD: a network meta-analysis Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 Efficacy and safety profile of xanthines in COPD: a network meta-analysis Source: Eur Respir Rev, 27 (148) 180010; 10.1183/16000617.0010-2018 Year: 2018 Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design Source: Eur Respir J 2001; 17: 329-336 Year: 2001 Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study Source: Eur Respir J 2010; 35: 532-539 Year: 2010 Late Breaking Abstract - Influence of salbutamol use on symptomatic outcomes with maintenance bronchodilators: a pre-specified analysis of the EMAX trial Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019 Prognostic factors of mortality and cardiovascular outcomes in the tiotropium safety and performance in respimat (TIOSPIR) trial Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: the real-life data Source: International Congress 2018 – Tests and trends in asthma Year: 2018 Cost effectiveness of budesonide/formoterol vs fluticasone/salmeterol: Real-world effectiveness and safety in COPD Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013